scholarly article | Q13442814 |
P356 | DOI | 10.7326/0003-4819-128-4-199802150-00005 |
P698 | PubMed publication ID | 9471930 |
P2093 | author name string | Quinn TC | |
Gaydos CA | |||
Howell MR | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Chlamydia trachomatis | Q131065 |
family planning | Q1280670 | ||
cost-effectiveness analysis | Q1754768 | ||
P304 | page(s) | 277-284 | |
P577 | publication date | 1998-02-01 | |
P1433 | published in | Annals of Internal Medicine | Q564416 |
P1476 | title | Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies | |
P478 | volume | 128 |
Q35092226 | American College of Preventive Medicine practice policy statement: screening for Chlamydia trachomatis |
Q37874745 | Barriers to screening sexually active adolescent women for chlamydia: a survey of primary care physicians. |
Q35530159 | Chlamydia trachomatis diagnostics |
Q35531472 | Chlamydia trachomatis prevalence in men in the mid-west of Ireland |
Q34548974 | Chlamydia trachomatisInfections in Female Soldiers, Israel |
Q37869010 | Clinical management of chlamydia and gonorrhea infection in a county teaching emergency department--concerns in overtreatment, undertreatment, and follow-up treatment success. |
Q37865219 | Comparison of DNA extraction from cervical cells collected in PreservCyt solution for the amplification of Chlamydia trachomatis |
Q35529396 | Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens. |
Q35021415 | Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies |
Q37835246 | Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women |
Q36272418 | Cost-effectiveness of universal screening for chlamydia and gonorrhea in US jails |
Q37869842 | Current Issues in Screening for Chlamydia trachomatis |
Q35627542 | Developments in the screening for Chlamydia trachomatis: a review |
Q37614736 | Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. |
Q33617158 | Estimating age-dependent per-encounter chlamydia trachomatis acquisition risk via a Markov-based state-transition model |
Q64118387 | Evaluation of the Performance of the Cobas CT/NG Test for Use on the Cobas 6800/8800 Systems for Detection of and in Male and Female Urogenital Samples |
Q37849297 | Female genital Chlamydia trachomatis infection: where are we heading? |
Q34222251 | Follow-up, treatment, and reinfection rates among asymptomatic chlamydia trachomatis cases in general practice. |
Q35562639 | High prevalence of genital Chlamydia trachomatis infection in women presenting in different clinical settings in Jamaica: implications for control strategies |
Q36059110 | Just the berries. Diagnosing Chlamydia trachomatis. |
Q35528964 | Low diagnostic accuracy of selective screening criteria for asymptomatic Chlamydia trachomatis infections in the general population |
Q35026625 | Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges. |
Q36928670 | Modelling the effectiveness of chlamydia screening in England |
Q35531545 | Modelling the healthcare costs of an opportunistic chlamydia screening programme |
Q35688390 | Optimizing strategies for population-based chlamydia infection screening among young women: an age-structured system dynamics approach |
Q35873375 | Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae |
Q34746935 | Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens |
Q37875570 | Point-of-entry screening for C. trachomatis In female army recruits. Who derives the cost savings? |
Q36314501 | Prevalence of Chlamydia trachomatis infection among low- and high-risk Filipino women and performance of Chlamydia rapid tests in resource-limited settings |
Q35530281 | Provider willingness to screen all sexually active adolescents for chlamydia |
Q36170683 | Reasons for testing women for genital Chlamydia trachomatis infection in the Calgary region |
Q33720510 | Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014 |
Q89456457 | Relationship between Chlamydia Trachomatis Infection with Patency Tubal and Non-Patency Tubal Occurrence in Infertile Women |
Q37853880 | Relative efficiency of chlamydia screening in non-clinical settings in two California counties |
Q43427394 | STD risk assessment and chlamydia screening: what's missing? |
Q37837870 | School-Based Sexually Transmitted Disease Screening: Review and Programmatic Guidance. |
Q42756958 | Screening for Chlamydia trachomatis. The case for screening is made, but much detail remains to be worked out. |
Q36491361 | Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling |
Q30986792 | Screening for chlamydial infection |
Q35888108 | Sexually transmitted diseases and managed care: an inquiry and review of issues affecting service delivery |
Q37877139 | Sexually transmitted diseases in women. Chlamydia trachomatis and herpes simplex infections |
Q35433936 | Sexually transmitted infections in Canada: A sticky situation |
Q77856216 | The Use of Urine and Self-obtained Vaginal Swabs for the Diagnosis of Sexually Transmitted Diseases |
Q36170984 | The laboratory diagnosis of Chlamydia trachomatis infections |
Q33666167 | Use of ligase chain reaction with urine versus cervical culture for detection of Chlamydia trachomatis in an asymptomatic military population of pregnant and nonpregnant females attending Papanicolaou smear clinics |
Q37875616 | Which women should be tested for Chlamydia trachomatis? |
Q37862992 | Women presenting with lower abdominal pain: a missed opportunity for chlamydia screening? |
Search more.